Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics (Nasdaq: AKBA) has scheduled the release of its second quarter 2025 financial results for Thursday, August 7, 2025, before market open. The company will host a conference call at 8:00 a.m. EDT on the same day to discuss the results and recent business developments.
Participants are encouraged to register in advance and join the call 15 minutes early to ensure timely connection. The presentation will be accessible via live webcast through Akebia's investor relations website, with an archived version available for later viewing.
Akebia Therapeutics (Nasdaq: AKBA) ha programmato la pubblicazione dei suoi risultati finanziari del secondo trimestre 2025 per giovedì 7 agosto 2025, prima dell'apertura dei mercati. La società terrà una conference call alle 8:00 a.m. EDT dello stesso giorno per discutere i risultati e gli sviluppi recenti del business.
Si invita i partecipanti a registrarsi in anticipo e a collegarsi 15 minuti prima per garantire una connessione puntuale. La presentazione sarà accessibile tramite webcast in diretta sul sito web delle relazioni con gli investitori di Akebia, con una versione archiviata disponibile per la visione successiva.
Akebia Therapeutics (Nasdaq: AKBA) ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el jueves 7 de agosto de 2025, antes de la apertura del mercado. La compañía llevará a cabo una llamada conferencia a las 8:00 a.m. EDT ese mismo día para discutir los resultados y los desarrollos recientes del negocio.
Se recomienda a los participantes registrarse con anticipación y unirse a la llamada 15 minutos antes para asegurar una conexión puntual. La presentación estará disponible vía webcast en vivo a través del sitio web de relaciones con inversionistas de Akebia, con una versión archivada para su visualización posterior.
Akebia Therapeutics (Nasdaq: AKBA)는 2025년 8월 7일 목요일 시장 개장 전에 2025년 2분기 재무 결과 발표를 예정하고 있습니다. 회사는 같은 날 오전 8:00 EDT에 컨퍼런스 콜을 개최하여 결과와 최근 사업 동향에 대해 논의할 예정입니다.
참가자들은 사전 등록을 권장하며, 원활한 연결을 위해 15분 일찍 접속할 것을 권장합니다. 프레젠테이션은 Akebia 투자자 관계 웹사이트를 통해 생중계 웹캐스트로 제공되며, 이후 다시 볼 수 있는 아카이브 버전도 제공됩니다.
Akebia Therapeutics (Nasdaq : AKBA) a prévu la publication de ses résultats financiers du deuxième trimestre 2025 pour le jeudi 7 août 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique à 8h00 EDT le même jour pour discuter des résultats et des développements récents de l'activité.
Les participants sont encouragés à s'inscrire à l'avance et à rejoindre l'appel 15 minutes plus tôt afin d'assurer une connexion dans les temps. La présentation sera accessible via un webcast en direct sur le site des relations investisseurs d'Akebia, avec une version archivée disponible pour une consultation ultérieure.
Akebia Therapeutics (Nasdaq: AKBA) hat die Veröffentlichung seiner Finanzergebnisse für das zweite Quartal 2025 für Donnerstag, den 7. August 2025, vor Markteröffnung geplant. Das Unternehmen wird am selben Tag um 8:00 Uhr EDT eine Telefonkonferenz abhalten, um die Ergebnisse und aktuelle Geschäftsentwicklungen zu besprechen.
Teilnehmer werden gebeten, sich im Voraus zu registrieren und 15 Minuten früher einzuwählen, um eine pünktliche Verbindung sicherzustellen. Die Präsentation wird über einen Live-Webcast auf der Investor-Relations-Website von Akebia zugänglich sein, wobei eine archivierte Version für spätere Ansicht verfügbar ist.
- None.
- None.
Akebia to Host Conference Call on August 7, 2025, at 8:00 a.m. EDT
CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, prior to the open of financial markets.
Akebia will host a conference call on Thursday, August 7, 2025, at 8:00 a.m. EDT to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
FAQ
When will Akebia Therapeutics (AKBA) report Q2 2025 earnings?
What time is Akebia's Q2 2025 earnings conference call?
How can investors access Akebia's Q2 2025 earnings call?
Where can I find the replay of Akebia's Q2 2025 earnings call?
